Short answer: A white label hormone therapy program lets your brand offer HRT for women and TRT for men under your own name, while a platform partner supplies branded intake, licensed provider evaluation, lab ordering, pharmacy fulfillment, subscriptions and refills. Licensed providers decide who is a candidate, and testosterone programs must follow DEA controlled substance rules.
A white label hormone therapy program is a build many founders ask us about. Founders, clinicians, med spas and wellness brands see the same thing: patients want thoughtful, ongoing hormone care, and they want it from a brand they trust. The white-label model lets you deliver that brand while licensed providers and licensed pharmacies handle the clinical side.
Hormone programs are also more demanding than most telehealth categories. They are lab-driven, they run for months or years, and testosterone brings federal controlled substance rules into the workflow. This guide explains how the white-label model works for hormones and what to ask of any partner before you launch.
What is a white label hormone therapy program?
In a white-label model, the patient sees your brand everywhere: your website, your intake, your portal and your emails. Behind it, a white-label telehealth platform runs the workflow that connects each patient to a licensed provider, routes lab orders and results, sends prescriptions to licensed pharmacies and manages subscriptions and follow-ups.
You run the brand and the business. Licensed providers make every clinical decision. How the business and clinical sides can be structured depends on your state, including corporate practice of medicine rules, so review your setup with a healthcare attorney before launch.
Two programs, one platform
Most hormone brands run one or both of these programs:
- White label HRT for women: perimenopause, menopause and postmenopause care, where a provider evaluates symptoms, history and risk factors and decides whether hormone therapy or another option fits.
- White label TRT for men: evaluation for testosterone deficiency, where labs confirm the picture and a DEA-registered provider decides whether testosterone is appropriate.
The two share infrastructure, but they differ in labs, regulation and monitoring. The table below shows where.
| Factor | HRT for women | TRT for men |
|---|---|---|
| Typical focus | Perimenopause and menopause symptoms | Symptoms consistent with low testosterone |
| Labs | Used when the provider calls for them, since hormone levels can fluctuate during perimenopause | Central to diagnosis, with repeat testing to confirm |
| Controlled substance rules | Estrogen and progesterone are not controlled, but any testosterone prescribed to women is Schedule III | Testosterone is Schedule III, so DEA rules apply |
| Screening focus | Contraindications such as certain cancers, blood clots, stroke and liver disease | Contraindications such as prostate or breast cancer, plus fertility goals and cardiovascular history |
| Ongoing monitoring | Symptom check-ins and provider review of the care plan | Repeat labs, hematocrit and blood pressure, on a provider-set schedule |
Why testosterone changes the rules: Schedule III and DEA
Testosterone is a Schedule III controlled substance under the Controlled Substances Act. That single fact shapes every white label TRT program, and any HRT program that includes testosterone for women.
- DEA registration. Prescribers need DEA registration, and generally a registration in each state where they prescribe to patients. Many states also require their own controlled substance registration.
- Telemedicine prescribing rules. The Ryan Haight Act generally requires an in-person evaluation before prescribing controlled substances online, with limited exceptions. The DEA telemedicine flexibilities have allowed DEA-registered practitioners to prescribe through audio-video telemedicine without a prior in-person visit. At the time of writing, those flexibilities are extended through December 31, 2026, and what follows is not settled.
- PDMP checks. Many states require prescribers to check the prescription drug monitoring program before prescribing certain controlled substances.
- Electronic prescribing. Controlled substance prescriptions sent electronically must go through a DEA-compliant EPCS workflow.
These rules change, and the stakes are high. Verify the current DEA and state rules with a healthcare attorney before you build a testosterone program, and again as any deadline approaches. For the full breakdown, read our guide on how to start a TRT digital clinic.
Labs before and during treatment
A hormone program is a lab program. Labs give the licensed provider objective information before any decision, and they anchor monitoring for as long as the patient stays in care.
Before treatment
For TRT, clinical guidelines recommend confirming low testosterone with morning lab tests, repeated to confirm, in men with consistent symptoms and signs. For HRT, labs are one input the provider weighs alongside age, history and symptoms, not an automatic answer. In both programs, the provider decides which tests to order.
During treatment
Follow-up labs let the provider review how the care plan is working and whether anything needs to change. Your platform should make repeat orders simple, route results into the chart and prompt the next check-in on schedule. Our guide on how to add lab testing to telehealth covers at-home kits, collection options and results workflows.
Provider evaluation in a white label hormone clinic
Every patient starts with a branded intake that collects symptoms, medical history, medications, family history and goals in plain language. The intake informs. The licensed provider decides.
The provider reviews the intake and labs, screens for contraindications, may ask follow-up questions or require a live visit, and then decides whether hormone therapy, another option or no treatment is right. For testosterone, the visit format has to meet DEA and state requirements, so a questionnaire alone should not be treated as enough. Our guide on asynchronous telehealth explains where async care fits and where it does not.
Ask your partner how its provider network is licensed, which states it covers for hormone care, which prescribers hold DEA registrations in which states, and how response times and clinical protocols are managed. Hormone care depends on continuity, so ask how patients are kept with a consistent care team over time.
Perimenopause and menopause programs
Women in midlife are often underserved by rushed, one-size-fits-all care. A dedicated brand can do better with respectful intake, clear education and consistent follow-up. The menopause transition can span years, which is why this category rewards brands built around long relationships.
Hormone therapy is not right for everyone. FDA guidance lists groups who should not take it, including people who may be pregnant or who have certain cancers, a history of stroke, heart attack or blood clots, or liver disease. Your intake should surface these clearly so the provider can decide. For the full playbook, read how to start a perimenopause and menopause telehealth clinic.
Pharmacy pathways for a white label hormone therapy program
Hormone programs can use two types of pharmacy pathways.
- Brand-name FDA-approved medications, dispensed by licensed pharmacies, with labeling and dosing defined by FDA approval.
- Compounded medications prepared by a licensed 503A pharmacy, for an individual patient based on a prescription. Compounded medications are not FDA-approved, and compounders face legal limits on making copies of commercially available approved drugs.
Never describe a compounded hormone as FDA-approved, safer or more natural than an approved product. For testosterone, confirm each pharmacy’s controlled substance handling and EPCS acceptance. Our guide on what a 503A pharmacy is explains the compounded pathway. A licensed provider decides whether any treatment is appropriate for a specific patient.
Ongoing monitoring, subscriptions and refills
Hormone care is long term, so the follow-up workflow is the program. Build these in from day one:
- Scheduled check-ins where patients report symptoms, side effects and questions.
- Repeat labs on a schedule the licensed provider sets.
- Provider-approved refills. Each refill is reviewed, and controlled substance refills follow DEA and state rules.
- Subscriptions that match the care plan, with clear pause and cancel options.
- Secure messaging so patients can reach the care team between visits.
- Patient education in your brand, so patients understand what comes next.
Marketing guardrails
Talk about evaluation, not outcomes. Never promise energy, strength, weight changes or symptom relief, never guarantee a prescription and never frame testosterone as an anti-aging product. Plan for LegitScript certification, since ad platforms and processors look for it, and controlled substance programs face extra review.
How to choose a white label hormone therapy program partner
Your partner becomes the engine behind your brand for years, so test it before you sign. Send every vendor the same questions and ask for written answers, since a polished demo is not a contract term.
- Does my brand appear everywhere patients see it, from intake to refill reminders?
- Which states does the provider network cover for hormone care, and which prescribers hold DEA registrations in which states?
- How are PDMP checks and EPCS prescribing handled for testosterone?
- Can providers order labs from a catalog, and do results land in the patient chart?
- Which brand-name and compounded 503A pathways are available, and how does each pharmacy handle controlled substances?
- How are check-ins, repeat labs and refills scheduled, and who approves each refill?
- Will you sign a business associate agreement, and what do you provide for my LegitScript application?
- How is pricing structured, and what happens to my patients and data if I leave?
A strong white label hormone therapy program partner answers all of these clearly. For the complete vendor checklist, see how to choose a white-label telehealth platform.
How WellieMD supports your hormone program
WellieMD is a white-label telehealth platform for digital clinics, and hormone therapy is one of the programs it runs. It provides branded intake, licensed provider review through a provider network, a lab catalog with results in the chart, wearables, pharmacy fulfillment through brand-name and compounded 503A pathways, a patient portal with messaging, follow-ups and refills, subscriptions, a branded patient education library, an admin dashboard with reporting, affiliate and referral links, and Meta and Google tracking setup, on HIPAA-ready infrastructure with 50-state coverage. Controlled substance requirements depend on your providers and states, so we walk through those specifics in your demo. Every clinical decision stays with licensed providers.
See the full view on the white-label telehealth platform page. If you want a team to build the brand around it, our sister company GrowPro is a separate launch service for branding, website, LegitScript application support, merchant setup and marketing. We build it with you.
Next step
A white label hormone therapy program works when every layer is built for long-term care: lab-first evaluation, DEA-compliant testosterone workflows, accurate pharmacy pathways and a brand patients want to stay with. If you are ready to plan your HRT or TRT program, book a WellieMD demo. To see the platform in action first, visit our video library.
This guide is general information, not legal or medical advice. Prescription products require evaluation by a licensed provider. Compounded medications are not FDA-approved.
Sources
- Federal Register: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
- Electronic Code of Federal Regulations: 21 CFR Part 1311, Requirements for Electronic Orders and Prescriptions
- Endocrine Society: Testosterone Therapy in Men with Hypogonadism clinical practice guideline
- U.S. Food and Drug Administration: Menopause
- U.S. Food and Drug Administration: Human drug compounding laws